The Combination of Predictive Factors of Pharmacokinetic Origin Associates with Enhanced Disease Control during Treatment of Pediatric Crohn’s Disease with Infliximab

Infliximab (IFX) concentrations are a predictive factor (PF) of pharmacokinetic (PK) origin in the treatment of Crohn’s disease (CD). We evaluated Clearance, another PF of PK origin, either alone or in combination with concentrations. They were evaluated from two cohorts, the first designed to recei...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubinsky, Marla C., Rabizadeh, Shervin, Panetta, John C., Spencer, Elizabeth A., Everts-van der Wind, Annelie, Dervieux, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610097/
https://www.ncbi.nlm.nih.gov/pubmed/37896168
http://dx.doi.org/10.3390/pharmaceutics15102408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610097/
https://www.ncbi.nlm.nih.gov/pubmed/37896168
http://dx.doi.org/10.3390/pharmaceutics15102408

Ejemplares similares